Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced its contribution to new research leveraging Multiplexed Assays ...
Nasdaq

Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification

SAN FRANCISCO, March 12, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced the launch of an update to Invitae Generation™ with Clinical Variant Modeling, a ...
Longview News-Journal

GenomOncology and Genomenon Partner to Enhance Germline Variant Classification and Genomic Reporting

CLEVELAND, Nov. 7, 2024 /PRNewswire/ -- GenomOncology, an a precision medicine software company, and Genomenon, a leading genomic intelligence company, today announced a strategic partnership aimed at ...
ascopubs.org

Clinically significant variant classification resulting from the addition of RNA sequencing: Experience at high-volume cancer genetics center.

Implementation of universal germline testing in underserved patients with young onset gastrointestinal cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...
ascopubs.org

Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop—Workshop Proceedings

Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma Next-generation sequencing ...
News Medical

New insights improve genetic classification for hereditary colorectal cancer

The genetic confirmation of a suspected diagnosis of "hereditary colorectal cancer" is of great importance for the medical care of affected families. However, many of the variants identified in the ...
Business Wire

Invitae Presents New Data Demonstrating High Concordance of Variant Classifications for BRCA1/2 Across Major Clinical Testing Laboratories

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today presented an important study at the 2016 American College of Medical Genetics and Genomics (ACMG) ...
Becker's Hospital Review

Delta now dominant globally; CDC updates variant labels— 5 updates

While the delta COVID-19 variant is the dominant strain in the U.S., it’s now officially the dominant strain worldwide “by far,” officials from the World Health Organization said during a Sept. 21 ...